cyclopentane has been researched along with Cancer of Endometrium in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Broaddus, R; Dai, H; Garnett, J; Hu, L; Jonasch, E; Kopetz, S; Lam, TNA; Li, Y; Liang, Y; Lin, SY; Lu, KH; McGrail, DJ; Menter, D; Mills, GB; Peng, G; Sahni, N; Schmandt, R; Shih, DJH; Sun, C; Wu, JY; Yates, MS; Yin, J | 1 |
| Bei, Q; Liu, H; Luo, X | 1 |
| Ignatov, A; Lattrich, C; Ortmann, O; Schüler, S; Skrzypczak, M; Treeck, O | 1 |
| Bruchim, I; Flescher, E; Reiss, A; Sarfstein, R; Werner, H | 1 |
4 other study(ies) available for cyclopentane and Cancer of Endometrium
| Article | Year |
|---|---|
Proteome Instability Is a Therapeutic Vulnerability in Mismatch Repair-Deficient Cancer.
Topics: Animals; Cell Line, Tumor; Colorectal Neoplasms; Cyclopentanes; DNA Mismatch Repair; Endometrial Neoplasms; Female; HCT116 Cells; Humans; Immunotherapy; Mice, Inbred C57BL; Mice, Transgenic; Microsatellite Instability; Mutation; NEDD8 Protein; Programmed Cell Death 1 Receptor; Protein Stability; Proteome; Pyrimidines; Xenograft Model Antitumor Assays | 2020 |
MLN4924 inhibits cell proliferation by targeting the activated neddylation pathway in endometrial carcinoma.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Cyclopentanes; Endometrial Neoplasms; Female; Humans; NEDD8 Protein; Pyrimidines; Ubiquitins | 2021 |
G protein-coupled estrogen receptor (GPER) expression in endometrial adenocarcinoma and effect of agonist G-1 on growth of endometrial adenocarcinoma cell lines.
Topics: Adenocarcinoma; Adult; Cell Line, Tumor; Cell Proliferation; Cyclopentanes; Endometrial Neoplasms; Endometrium; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Humans; Membrane Proteins; Middle Aged; PTEN Phosphohydrolase; Quinolines; Receptors, Estrogen; Receptors, G-Protein-Coupled; Receptors, Progesterone; RNA, Messenger | 2013 |
IGF1R tyrosine kinase inhibitor enhances the cytotoxic effect of methyl jasmonate in endometrial cancer.
Topics: Acetates; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cyclopentanes; Dose-Response Relationship, Drug; Endometrial Neoplasms; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Oxylipins; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrimidines; Pyrroles; Receptor, IGF Type 1; Time Factors | 2014 |